Announced

Completed

Hypera completed the acquisition of Buscopan brand from Boehringer Ingelheim for $319m.

Synopsis

Hypera, Brazilian pharmaceutical company, completed the acquisition of Buscopan brand from Boehringer Ingelheim, the second largest animal health business in the world, for $319m.

Principals

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Hypera completed the acquisition of Buscopan brand from Boehringer Ingelheim for $319m.